Nanomedicine News

RSS

Epigem Contributes Biocompatible Microfluidic Modules for EU-funded Rare Anaemia Treatments Project

Epigem, a high-tech British micro engineering company, has made a major contribution to the EU-funded CoMMiTMenT (Combined Molecular Microscopy for Therapy and Personalised Medication in Rare Anaemia Treatments) project, a significant steptowards the creation of an ‘artificial spleen’.

From Epigem Ltd. 29 Oct 2014

Novavax Presents Ebola GP Recombinant Nanoparticle Vaccine Candidate at 8th Vaccine and ISV Conference

Novavax, Inc. today announced that Gale Smith, Ph.D., Vice President of Vaccine Development at Novavax, presented at the 8th Vaccine and ISV Conference in Philadelphia on Sunday, October 26. Dr. Smith's presentation was titled: 2014 Guinea Ebola Virus Recombinant Glycoprotein (GP) Nanoparticle Vaccine was Highly Immunogenic and Cross-Neutralized 1976 Virus GP Pseudovirus.

From Novavax Inc. 28 Oct 2014

Case Western Receives Grant for Study on Nanotechnology for Treatment of Pediatric Glioma Brain Tumors

Prayers from Maria Children's Glioma Cancer Foundation announced today that it will award its $250,000 Melana Matson Memorial Grant—its third major research grant since 2010—to Case Western Reserve University, Case Comprehensive Cancer Center researchers James Basilion, PhD, Efstathis Karathanasis, PhD, and John Letterio, MD, who are studying the use of nanotechnology to more effectively treat pediatric glioma brain tumors.

28 Oct 2014

USAMRIID Scientists to Evaluate Nanoviricides Anti-Ebola Drug Candidates

NanoViricides, Inc., a nanomedicine company developing anti-viral drugs, announced today that it has executed a CRADA (Collaborative Research and Development Agreement for Material Transfer) with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID).

From NanoViricides, Inc 28 Oct 2014

New Data from Novavax' RSV F-Protein Nanoparticle Vaccine Trial Presented at 8th Vaccine & ISV Congress

Novavax, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, announced today that Gregory Glenn, M.D., SVP, Research and Development is presenting new immunogenicity data from Novavax' RSV F-Protein Nanoparticle vaccine candidate (RSV F vaccine) clinical trials at the 8th Vaccine & ISV Congress in Philadelphia, PA.

From Novavax Inc. 27 Oct 2014

NanoSIMS Helps Trace How Liver, Brain Cells Store and Metabolize Glycogen

Scientists at EPFL have used a new imaging technique to monitor how glucose, our main energy source, is used in the body. Their findings may have great implications for diseases like diabetes.

27 Oct 2014

Nanoscale Device Can Rapidly Gauge Optimal Dose of Potentially Toxic Cancer Drug

In less than a minute, a miniature device developed at the University of Montreal can measure a patient's blood for methotrexate, a commonly used but potentially toxic cancer drug. Just as accurate and ten times less expensive than equipment currently used in hospitals, this nanoscale device has an optical system that can rapidly gauge the optimal dose of methotrexate a patient needs, while minimizing the drug's adverse effects. The research was led by Jean-François Masson and Joelle Pelletier of the university's Department of Chemistry.

27 Oct 2014

CASIS Awards Grant to Develop Remotely Controlled Nanochannel Drug Delivery System

Houston Methodist Research Institute scientists will receive about $1.25 million from the Center for the Advancement of Science in Space to develop an implantable device that delivers therapeutic drugs at a rate guided by remote control. The device's effectiveness will be tested aboard the International Space Station and on Earth's surface.

27 Oct 2014

Novel Nanoparticle Delivers Melanoma-Fighting Drug Directly to the Cancer

Penn State College of Medicine researchers have developed a nanoparticle to deliver a melanoma-fighting drug directly to the cancer.

25 Oct 2014

New Report on Global Market for Anti-Microbial Nanocoatings

Research and Markets has announced the addition of the "The Global Market for Anti-Microbial Nanocoatings" report to their offering.

25 Oct 2014

Nanomedicine News

Epigem Contributes Biocompatible Microfluidic Modules for EU-funded Rare Anaemia Treatments Project

Novavax Presents Ebola GP Recombinant Nanoparticle Vaccine Candidate at 8th Vaccine and ISV Conference

Case Western Receives Grant for Study on Nanotechnology for Treatment of Pediatric Glioma Brain Tumors

USAMRIID Scientists to Evaluate Nanoviricides Anti-Ebola Drug Candidates

New Data from Novavax' RSV F-Protein Nanoparticle Vaccine Trial Presented at 8th Vaccine & ISV Congress

NanoSIMS Helps Trace How Liver, Brain Cells Store and Metabolize Glycogen

Nanoscale Device Can Rapidly Gauge Optimal Dose of Potentially Toxic Cancer Drug

CASIS Awards Grant to Develop Remotely Controlled Nanochannel Drug Delivery System

Novel Nanoparticle Delivers Melanoma-Fighting Drug Directly to the Cancer

New Report on Global Market for Anti-Microbial Nanocoatings

Combining Nanofluids and Turbulators for Sustainable Energy

Enhancing Material Properties through Nanotube Encapsulation

Brain-Inspired Nano-Tech Promises New Era for Electronics

Breakthrough in 2D Material Growth Opens Doors to Cleaner Energy and Next-Generation Technology

Sustainable Carbon Nanomaterial Gii Set to Transform Energy Storage in Internet of Things Devices

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Conversations on AFM: Applications of BioAFM in Life Science

Sponsored Content

Characterization of Active Pharmaceutical Ingredients, Injectables, and Proteins

The Future of Wound Care: Why Nanofibers are Key to Accelerated Healing

The Evolution of Lipid Nanoparticles

How Emulsion Electrospinning is Transforming Materials